Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 366 articles:
HTML format



Single Articles


    November 2021
  1. WEI J, Tong K, Wang H, Wen Y, et al
    Intra-articular vancomycin for the prophylaxis of periprosthetic joint infection caused by methicillin-resistant S. aureus after total knee arthroplasty in a rat model: the dosage, efficacy, and safety.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0164121. doi: 10.1128/AAC.01641.
    PubMed     Abstract available


  2. VOGENSEN VB, Bolhuis MS, Sturkenboom MGG, van der Werf TS, et al
    Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0182921. doi: 10.1128/AAC.01829.
    PubMed     Abstract available


  3. LEE YL, Ko WC, Hsueh PR
    Geographic Patterns of Carbapenem-resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2015-2019.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0200021. doi: 10.1128/AAC.02000.
    PubMed     Abstract available


  4. CRANDON JL, Kuti JL, Nicolau DP
    Erratum for Crandon et al., "Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model".
    Antimicrob Agents Chemother. 2021;65:e0187821.
    PubMed    


  5. RIVAS L, Alcalde-Rico M, Martinez JR, Moreno V, et al
    Real-world Performance of Susceptibility Testing for Ceftolozane/Tazobactam Against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0165721. doi: 10.1128/AAC.01657.
    PubMed     Abstract available


  6. PHAN MD, Peters KM, Alvarez Fraga L, Wallis SC, et al
    Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0214621. doi: 10.1128/AAC.02146.
    PubMed     Abstract available


  7. LIAO YS, Chen BH, Teng RH, Wang YW, et al
    Antimicrobial resistance in Campylobacter coli and Campylobacter jejuni from human campylobacteriosis in Taiwan, 2016-2019.
    Antimicrob Agents Chemother. 2021 Nov 8:AAC0173621. doi: 10.1128/AAC.01736.
    PubMed     Abstract available


  8. KARAU MJ, Schmidt-Malan SM, Cunningham SA, Mandrekar JN, et al
    Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Nov 1:AAC0170321. doi: 10.1128/AAC.01703.
    PubMed     Abstract available


    October 2021
  9. MISHRA NN, Lew C, Abdelhady W, Lapitan CK, et al
    Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant S. aureus: In vitro, Ex vivo and In vivo Metrics.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0164921. doi: 10.1128/AAC.01649.
    PubMed     Abstract available


  10. ANAHTAR MN, Bramante JT, Xu J, Desrosiers LA, et al
    Prediction of antimicrobial resistance in clinical Enterococcus faecium isolates using a rules-based analysis of whole genome sequences.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0119621. doi: 10.1128/AAC.01196.
    PubMed     Abstract available


  11. JIANG S, Zhuang H, Zhu F, Wei X, et al
    The role of mprF mutations in "see-saw effect" of Daptomycin-resistant methicillin-resistant Staphylococcus aureus isolates.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0129521. doi: 10.1128/AAC.01295.
    PubMed     Abstract available


  12. DEMCZUK W, Martin I, Griffith A, Lefebvre B, et al
    Linear regression equations to predict beta-lactam, macrolide, lincosamide and fluoroquinolone minimum inhibitory concentrations from molecular antimicrobial resistance determinants in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0137021. doi: 10.1128/AAC.01370.
    PubMed     Abstract available


  13. KARLOWSKY JA, Hackel MA, Sahm DF
    In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0130421. doi: 10.1128/AAC.01304.
    PubMed     Abstract available


  14. ALZAYN M, Dulyayangkul P, Satapoomin N, Heesom KJ, et al
    OmpF Downregulation Mediated by Sigma E or OmpR Activation Confers Cefalexin Resistance in Escherichia coli in the Absence of Acquired beta-Lactamases.
    Antimicrob Agents Chemother. 2021;65:e0100421.
    PubMed     Abstract available


  15. NORDMANN P, Yao Y, Falgenhauer L, Sadek M, et al
    Recent Emergence of Aztreonam-Avibactam Resistance in NDM and OXA-48 Carbapenemase-Producing Escherichia coli in Germany.
    Antimicrob Agents Chemother. 2021;65:e0109021.
    PubMed    


  16. CHENG Q, Zheng Z, Ye L, Chen S, et al
    Identification of a Novel Metallo-beta-Lactamase, VAM-1, in a Foodborne Vibrio alginolyticus Isolate from China.
    Antimicrob Agents Chemother. 2021;65:e0112921.
    PubMed     Abstract available


  17. OSTRER L, Ji Y, Khodursky A
    Identification and Characterization of Pleiotropic High-Persistence Mutations in the Beta Subunit of the Bacterial RNA Polymerase.
    Antimicrob Agents Chemother. 2021;65:e0052221.
    PubMed     Abstract available


  18. PORAMATHIKUL K, Wojnarski M, Sok S, Sokh V, et al
    Update on Shigella and Nontyphoidal Salmonella Antimicrobial Drug Resistance: Implications on Empirical Treatment of Acute Infectious Diarrhea in Cambodia.
    Antimicrob Agents Chemother. 2021;65:e0067121.
    PubMed     Abstract available


  19. LOVEY A, Krel M, Borchardt A, Brady T, et al
    Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections.
    Antimicrob Agents Chemother. 2021;65:e0098521.
    PubMed     Abstract available


  20. ZAIDAN N, Hornak JP, Reynoso D
    Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
    Antimicrob Agents Chemother. 2021;65:e0092421.
    PubMed     Abstract available


  21. BECKA SA, Zeiser ET, LiPuma JJ, Papp-Wallace KM, et al
    Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli.
    Antimicrob Agents Chemother. 2021;65:e0133221.
    PubMed     Abstract available


  22. CUBRIA MB, Vega LA, Shropshire WC, Sanson MA, et al
    Population genomics reveals distinct temporal association with the emergence of ST1 serotype V Group B Streptococcus and macrolide resistance in North America.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0071421. doi: 10.1128/AAC.00714.
    PubMed     Abstract available


  23. EVERT BJ, Slesarenko VA, Punnasseril JMJ, Taha, et al
    Self-inhibitory peptides targeting the Neisseria gonorrhoeae MtrCDE efflux pump increase antibiotic susceptibility.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0154221. doi: 10.1128/AAC.01542.
    PubMed     Abstract available


  24. JACQUELINE C, Caillon J, Meyer O, Dailly E, et al
    Efficacy of Nano-Encapsulated Daptomycin in an Experimental Methicillin-Resistant Staphylococcus aureus (MRSA) Bone and Joint Infection Model.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0076821. doi: 10.1128/AAC.00768.
    PubMed     Abstract available


    September 2021
  25. SABOUR S, Huang JY, Bhatnagar A, Gilbert SE, et al
    Detection and Characterization of Targeted Carbapenem-Resistant Healthcare-Associated Threats: Findings from The Antibiotic Resistance Laboratory Network, 2017-2019.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0110521. doi: 10.1128/AAC.01105.
    PubMed     Abstract available


  26. COX GW, Parmley EJ, Avery BP, Irwin RJ, et al
    A one health genomic investigation of gentamicin resistance in Salmonella from human and chicken sources in Canada, 2014-2017.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0096621. doi: 10.1128/AAC.00966.
    PubMed     Abstract available


  27. INGLE DJ, Andersson P, Valcanis M, Wilmot M, et al
    Genomic epidemiology and antimicrobial resistance mechanisms of imported typhoid in Australia.
    Antimicrob Agents Chemother. 2021 Sep 20:AAC0120021. doi: 10.1128/AAC.01200.
    PubMed     Abstract available


  28. KORRY BJ, Lee SYE, Chakrabarti AK, Choi AH, et al
    Genotoxic Agents Produce Stressor-Specific Spectra of Spectinomycin Resistance Mutations Based on Mechanism of Action and Selection in Bacillus subtilis.
    Antimicrob Agents Chemother. 2021;65:e0089121.
    PubMed     Abstract available


  29. HE YZ, Yan JR, He B, Ren H, et al
    A Transposon-Associated CRISPR/Cas9 System Specifically Eliminates both Chromosomal and Plasmid-Borne mcr-1 in Escherichia coli.
    Antimicrob Agents Chemother. 2021;65:e0105421.
    PubMed     Abstract available


  30. HANDELMAN M, Meir Z, Scott J, Shadkchan Y, et al
    Point Mutation or Overexpression of Aspergillus fumigatus cyp51B, Encoding Lanosterol 14alpha-Sterol Demethylase, Leads to Triazole Resistance.
    Antimicrob Agents Chemother. 2021;65:e0125221.
    PubMed     Abstract available


  31. SLIPSKI CJ, Jamieson-Datzkiw TR, Zhanel GG, Bay DC, et al
    Characterization of Proteobacterial Plasmid Integron-Encoded qac Efflux Pump Sequence Diversity and Quaternary Ammonium Compound Antiseptic Selection in Escherichia coli Grown Planktonically and as Biofilms.
    Antimicrob Agents Chemother. 2021;65:e0106921.
    PubMed     Abstract available


  32. POIREL L, Sadek M, Nordmann P
    Contribution of PER-Type and NDM-Type beta-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65:e0087721.
    PubMed     Abstract available


  33. CRASS RL, Al Naimi T, Wen B, Souza E, et al
    Pharmacokinetics of Polymyxin B in Hospitalized Adults with Cystic Fibrosis.
    Antimicrob Agents Chemother. 2021;65:e0079221.
    PubMed     Abstract available


    August 2021
  34. PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
    Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 (Meropenem/Piperacillin/Tazobactam) for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia in Immunocompetent Rabbits with Chronic Indwelling Vascular Catheters.
    Antimicrob Agents Chemother. 2021 Aug 30:AAC0116821. doi: 10.1128/AAC.01168.
    PubMed     Abstract available


  35. VARGAS R JR, Freschi L, Spitaleri A, Tahseen S, et al
    The role of epistasis in amikacin, kanamycin, bedaquiline, and clofazimine resistance in Mycobacterium tuberculosis complex.
    Antimicrob Agents Chemother. 2021 Aug 30:AAC0116421. doi: 10.1128/AAC.01164.
    PubMed     Abstract available


  36. HOWARD-ANDERSON J, van Duin D
    Uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0142421. doi: 10.1128/AAC.01424.
    PubMed     Abstract available


  37. MUKHERJEE S, Blankenship HM, Rodrigues JA, Mosci RE, et al
    Antibiotic susceptibility profiles and frequency of resistance genes in clinical Shiga toxin-producing Escherichia coli isolates from Michigan over a 14-year period.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0118921. doi: 10.1128/AAC.01189.
    PubMed     Abstract available


  38. PASCUA PNQ, Jones JC, Marathe BM, Seiler P, et al
    Baloxavir treatment delays influenza B virus transmission in ferrets and results in limited generation of drug-resistant variants.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0113721. doi: 10.1128/AAC.01137.
    PubMed     Abstract available


  39. WANG CH, Siu LK, Chang FY, Tsai YK, et al
    Erratum for Wang et al., "A Novel Deletion Mutation in pmrB Contributes to Concurrent Colistin Resistance in Carbapenem-Resistant Escherichia coli Sequence Type 405 of Clinical Origin".
    Antimicrob Agents Chemother. 2021;65:e0137421.
    PubMed    


  40. WEI J, Wen Y, Tong K, Wang H, et al
    Local Application of Vancomycin in One-Stage Revision of Prosthetic Joint Infection Caused by Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021;65:e0030321.
    PubMed     Abstract available


  41. ABDUL-MUTAKABBIR JC, Nguyen L, Maassen PT, Stamper KC, et al
    In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65:e0264620.
    PubMed     Abstract available


  42. CHOQUET M, Lohou E, Pair E, Sonnet P, et al
    Efflux Pump Overexpression Profiling in Acinetobacter baumannii and Study of New 1-(1-Naphthylmethyl)-Piperazine Analogs as Potential Efflux Inhibitors.
    Antimicrob Agents Chemother. 2021;65:e0071021.
    PubMed     Abstract available


  43. GILL CM, Aktathorn E, Alfouzan W, Bourassa L, et al
    Elevated MICs of Susceptible Anti-Pseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization.
    Antimicrob Agents Chemother. 2021 Aug 16:AAC0120421. doi: 10.1128/AAC.01204.
    PubMed     Abstract available


  44. NGWALERO P, Brust JCM, van Beek SW, Wasserman S, et al
    Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0239920. doi: 10.1128/AAC.02399.
    PubMed     Abstract available


  45. JEHANNE Q, Benejat L, Ducournau A, Domingues-Martins C, et al
    Emergence of erythromycin resistance methyltransferases in Campylobacter coli strains in France.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0112421. doi: 10.1128/AAC.01124.
    PubMed     Abstract available


  46. HORWICH-SCHOLEFIELD S, Lloyd T, Varghese V, Yette E, et al
    Imipenem-Relebactam Susceptibility and Genotypic Characteristics of Carbapenem-Resistant Enterobacterales (CRE) Identified during Population-Based Surveillance.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0228820. doi: 10.1128/AAC.02288.
    PubMed     Abstract available


  47. ESPINEL-INGROFF A, Sasso M, Turnidge J, Arendrup M, et al
    Etest ECVs/ECOFFs for detection of resistance in prevalent and three non-prevalent Candida spp. to triazoles and amphotericin B and Aspergillus spp. to caspofungin: Further assessment of modal variability.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0109321. doi: 10.1128/AAC.01093.
    PubMed     Abstract available


  48. PRUSSING C, Canulla T, Singh N, McAuley P, et al
    Characterization of the first carbapenem-resistant Pseudomonas aeruginosa clinical isolate harboring blaSIM-1 from the United States.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0106621. doi: 10.1128/AAC.01066.
    PubMed     Abstract available


  49. KULARATNE RS, Kufa T, Gumede L, Maseko DV, et al
    Demographic and behavioural risk factors associated with reduced susceptibility of Neisseria gonorrhoeae to first-line antimicrobials in South African men with gonococcal urethral discharge.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0038921. doi: 10.1128/AAC.00389.
    PubMed     Abstract available


    July 2021
  50. KAWAI A, Suzuki M, Tsukamoto K, Minato Y, et al
    Functional and Structural Characterization of Acquired Pan-Aminoglycoside Resistance 16S rRNA Methyltransferase NpmB1.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0100921. doi: 10.1128/AAC.01009.
    PubMed     Abstract available


  51. WANG J, Ma W, Fang Y, Liang H, et al
    Core oligosaccharide portion of lipopolysaccharide plays important roles on multiple antibiotic resistance in Escherichia coli.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0034121. doi: 10.1128/AAC.00341.
    PubMed     Abstract available


  52. GILL CM, Brink A, Chu CY, Coetzee J, et al
    The Phenotypic/Genotypic Profile of OXA-10-like harboring, Carbapenem-Resistant Pseudomonas aeruginosa: Using Validated Pharmacokinetic/Pharmacodynamic in vivo Models to Further Evaluate Enzyme Functionality and Clinical Implications.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0127421. doi: 10.1128/AAC.01274.
    PubMed     Abstract available


  53. SHAHEEN SK, Juvvadi PR, Allen Iv J, Shwab EK, et al
    In vitro activity of APX2041, a new GWT1-inhibitor and in vivo efficacy of the prodrug APX2104 against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0068221. doi: 10.1128/AAC.00682.
    PubMed     Abstract available


  54. MITCHEV N, Singh R, Allam M, Kwenda S, et al
    Antimicrobial resistance mechanisms, MLST and NG-STAR sequence types of diverse Neisseria gonorrhoeae isolates in KwaZulu-Natal, South Africa.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0075921. doi: 10.1128/AAC.00759.
    PubMed     Abstract available


  55. LE C, Pimentel C, Tuttobene MR, Subils T, et al
    Interplay between meropenem and human serum albumin on expression of carbapenem resistance genes and natural competence in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0101921. doi: 10.1128/AAC.01019.
    PubMed     Abstract available


  56. HANDELMAN M, Morogovsky A, Liu W, Ben-Ami R, et al
    Triazole resistant Aspergillus fumigatus in an Israeli patient with Chronic Cavitary Pulmonary Aspergillosis due to a novel E306K Substitution in Hmg1.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0108921. doi: 10.1128/AAC.01089.
    PubMed     Abstract available


  57. SARDANA K, Gupta A, Sadhasivam S, Gautam RK, et al
    Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.
    Antimicrob Agents Chemother. 2021;65:e0032121.
    PubMed     Abstract available


  58. CHEW KL, Octavia S, Lai D, Lin RTP, et al
    Genomic Characterization of Klebsiella quasipneumoniae from Clinical Specimens in Singapore.
    Antimicrob Agents Chemother. 2021;65:e0041221.
    PubMed     Abstract available


  59. MCCREARY EK, Heil EL, Tamma PD
    New Perspectives on Antimicrobial Agents: Cefiderocol.
    Antimicrob Agents Chemother. 2021;65:e0217120.
    PubMed     Abstract available


  60. ZUBYK HL, Wright GD
    CrpP Is Not a Fluoroquinolone-Inactivating Enzyme.
    Antimicrob Agents Chemother. 2021;65:e0077321.
    PubMed    


  61. KONG X, Tang C, Singh A, Ahmed SA, et al
    Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex.
    Antimicrob Agents Chemother. 2021;65:e0005621.
    PubMed     Abstract available


  62. SERRANO-LOBO J, Gomez A, Rodriguez-Sanchez B, Munoz P, et al
    Azole resistant Aspergillus fumigatus clinical isolate screening in azole-containing agar plates (EUCAST E.Def 10.1): low impact of plastic trays used and poor performance in cryptic species.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0048221. doi: 10.1128/AAC.00482.
    PubMed     Abstract available


  63. POUVARET A, Dureault A, Garcia-Hermoso D, Serris A, et al
    Combined high dose caspofungin and liposomal amphotericin B for the treatment of azole-resistant cerebral aspergillosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0047421. doi: 10.1128/AAC.00474.
    PubMed     Abstract available


  64. BIGGEL M, Nuesch-Inderbinen M, Jans C, Stevens MJA, et al
    Genetic context of optrA and poxtA in florfenicol-resistant enterococci isolated from flowing surface water in Switzerland.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0108321. doi: 10.1128/AAC.01083.
    PubMed     Abstract available


  65. WESTGEEST AC, Schippers EF, Delfos NM, Ellerbroek LJ, et al
    Complicated carriage with methicillin-resistant Staphylococcus aureus (MRSA): evaluation of the effectiveness of decolonization regimens advised in the Dutch national guideline.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0025721. doi: 10.1128/AAC.00257.
    PubMed     Abstract available


  66. TRAUNER A, Banaei-Esfahani A, Gygli SM, Warmer P, et al
    Expression dysregulation as a mediator of fitness costs in antibiotic resistance.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0050421. doi: 10.1128/AAC.00504.
    PubMed     Abstract available


  67. CHEN L, Han X, Li Y, Li M, et al
    Assessment of mortality-related risk factors and effective antimicrobial regimens for the treatment of bloodstream infections caused by carbapenem-resistant Enterobacterales.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0069821. doi: 10.1128/AAC.00698.
    PubMed     Abstract available


  68. MAPHANGA TG, Naicker SD, Kwenda S, Munoz JF, et al
    In-vitro antifungal resistance of Candida auris isolates from bloodstream infections, South Africa.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0051721. doi: 10.1128/AAC.00517.
    PubMed     Abstract available


    June 2021
  69. SOMPRASONG N, Yi J, Hall CM, Webb JR, et al
    Conservation of resistance nodulation cell division efflux pump mediated antibiotic resistance in Burkholderia cepacia complex and Burkholderia pseudomallei complex species.
    Antimicrob Agents Chemother. 2021 Jun 28:AAC0092021. doi: 10.1128/AAC.00920.
    PubMed     Abstract available


  70. WERNGREN J, Mansjo M, Glader M, Hoffner S, et al
    Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 28:AAC0072021. doi: 10.1128/AAC.00720.
    PubMed     Abstract available


  71. FERREIRA S, Silva AL, Tomas J, Mateus C, et al
    Characterization of AreABC, an RND-type efflux system involved in antimicrobial resistance of Aliarcobacter butzleri.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0072921. doi: 10.1128/AAC.00729.
    PubMed     Abstract available


  72. GONZALEZ-JIMENEZ I, Garcia-Rubio R, Monzon S, Lucio J, et al
    Multi-resistance to non-azole fungicides in Aspergillus fumigatus TR34/L98H azole resistant isolates.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0064221. doi: 10.1128/AAC.00642.
    PubMed     Abstract available


  73. PLAUNT AJ, Rose SJ, Kang JY, Chen KJ, et al
    Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2021;65:e0031621.
    PubMed     Abstract available


  74. KORNELSEN V, Kumar A
    Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.
    Antimicrob Agents Chemother. 2021;65:e0051421.
    PubMed     Abstract available


  75. ZARROUK K, Zhu X, Pham VD, Goyette N, et al
    Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
    Antimicrob Agents Chemother. 2021;65:e0039021.
    PubMed     Abstract available


  76. LIZZA BD, Betthauser KD, Ritchie DJ, Micek ST, et al
    New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65:e0231820.
    PubMed     Abstract available


  77. GUTHRIDGE I, Smith S, Law M, Binotto E, et al
    The efficacy and safety of intravenous lincosamide therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0034321. doi: 10.1128/AAC.00343.
    PubMed     Abstract available


  78. TOYOTOME T, Onishi K, Sato M, Kusuya Y, et al
    Identification of novel mutations contributing to azole tolerance of Aspergillus fumigatus through in vitro exposure to tebuconazole.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0265720. doi: 10.1128/AAC.02657.
    PubMed     Abstract available


  79. HUANG DB, Gaukel E, Kerzee N, Borroto-Esoda K, et al
    Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0050821. doi: 10.1128/AAC.00508.
    PubMed     Abstract available


  80. LEW C, Mishra NN, Bayer AS, Rose WE, et al
    beta-lactam-induced cell envelope adaptations, not solely enhanced daptomycin binding, underlies daptomycin-beta-lactam synergy in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0035621. doi: 10.1128/AAC.00356.
    PubMed     Abstract available


  81. GUO Q, Zhang Y, Fan J, Zhang H, et al
    MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0033021. doi: 10.1128/AAC.00330.
    PubMed     Abstract available


  82. ABOU FAYAD AG, Haraoui LP, Sleiman A, Jaafar M, et al
    Diversity of sequence types and impact of fitness cost among carbapenem-resistant Acinetobacter baumannii isolates from Tripoli, Libya.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0027721. doi: 10.1128/AAC.00277.
    PubMed     Abstract available


  83. WANG C, Yin M, Zhang X, Guo Q, et al
    Identification of qnrE3 and qnrE4, new transferable quinolone resistance qnrE family genes originating from Enterobacter mori and E. asburiae, respectively.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0045621. doi: 10.1128/AAC.00456.
    PubMed     Abstract available


  84. LUCASSEN K, Gerson S, Xanthopoulou K, Wille J, et al
    Comparison of the A. baumannii reference strains ATCC 17978 and ATCC 19606 in antimicrobial resistance mediated by the AdeABC efflux pump.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0057021. doi: 10.1128/AAC.00570.
    PubMed     Abstract available


  85. BACCANI I, Antonelli A, Di Pilato V, Coppi M, et al
    Detection of poxtA2, a presumptive poxtA ancestor, in a plasmid from a linezolid-resistant Enterococcus gallinarum.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0069521. doi: 10.1128/AAC.00695.
    PubMed     Abstract available


  86. BHATNAGAR A, Boyd S, Sabour S, Bodnar J, et al
    Aztreonam-Avibactam Susceptibility Testing Program for Metallo-beta-lactamase-producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019-December 2020.
    Antimicrob Agents Chemother. 2021 Jun 1:AAC0048621. doi: 10.1128/AAC.00486.
    PubMed     Abstract available


    May 2021
  87. RUBIO AM, Kline EG, Jones CE, Chen L, et al
    In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  88. SOLIMAN AM, Ramadan H, Zarad H, Sugawara Y, et al
    Coproduction of Tet(X7) Conferring High-Level Tigecycline Resistance, Fosfomycin FosA4, and Colistin Mcr-1.1 in Escherichia coli Strains from Chickens in Egypt.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  89. DESNOS-OLLIVIER M, Lortholary O, Bretagne S, Dromer F, et al
    Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  90. MOIRANGTHEM R, Kumar K, Kaur R
    Two Functionally Redundant FK506-Binding Proteins Regulate Multidrug Resistance Gene Expression and Govern Azole Antifungal Resistance.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  91. SOBEL JD, Borroto-Esoda K, Azie N, Angulo D, et al
    In Vitro pH Activity of Ibrexafungerp Against Fluconazole-susceptible and -resistant Candida Isolates from Women with Vulvovaginal Candidiasis.
    Antimicrob Agents Chemother. 2021 May 17. pii: AAC.00562.
    PubMed     Abstract available


  92. CHEUNG CHP, Alorabi M, Hamilton F, Takebayashi Y, et al
    Trade-Offs Between Antibacterial Resistance and Fitness Cost in the Production of Metallo-beta-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02412.
    PubMed     Abstract available


  93. RUELENS P, de Visser JAGM
    Choice of beta-lactam resistance pathway depends critically on initial antibiotic concentration.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00471.
    PubMed     Abstract available


  94. MCGUIRE RJ, Yu SC, Payne PRO, Lai AM, et al
    A Pragmatic Machine Learning Model to Predict Carbapenem Resistance.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00063.
    PubMed     Abstract available


  95. KAZMIERCZAK KM, Karlowsky JA, de Jonge BLM, Stone GG, et al
    Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-nonsusceptible Enterobacterales collected as part of a Global Surveillance Program, 2012-2017.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02000.
    PubMed     Abstract available


  96. DARLOW CA, Docobo-Perez F, Farrington N, Johnson A, et al
    Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00293.
    PubMed     Abstract available


  97. FREDERICKS LR, Lee MD, Eckert HR, Li S, et al
    Vaginal Isolates of Candida glabrata are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02450.
    PubMed     Abstract available


  98. MOK S, Roycroft E, Flanagan PR, Montgomery L, et al
    Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis isolates.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02617.
    PubMed     Abstract available


  99. JANICE J, Agyepong N, Owusu-Ofori A, Govinden U, et al
    Carbapenem-resistance determinants acquired through novel chromosomal integrations in XDR Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00289.
    PubMed     Abstract available


  100. LIANG T, Yang X, Li R, Yang E, et al
    Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00263.
    PubMed     Abstract available


    April 2021
  101. LEY SD, Pillay S, Streicher EM, van der Heijden YF, et al
    Melting the Eis: non-detection of kanamycin resistance markers by routine diagnostic tests and identification of new eis-promoter variants.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02502.
    PubMed     Abstract available


  102. KIM DH, Kim SY, Koh WJ, Jhun BW, et al
    In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02306.
    PubMed     Abstract available


  103. SONNENKALB L, Strohe G, Dreyer V, Andres S, et al
    Microevolution of Mycobacterium tuberculosis hetero-resistance subpopulations in a patient receiving 27 years of tuberculosis treatment in Germany.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02520.
    PubMed     Abstract available


  104. CRANE JK, Alvarado CL, Sutton MD
    Role of the SOS Response in the Generation of Antibiotic Resistance In Vivo.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00013.
    PubMed     Abstract available


  105. REHMAN A, Jeukens J, Levesque RC, Lamont IL, et al
    Gene-gene interactions dictate ciprofloxacin resistance in Pseudomonas aeruginosa and facilitate prediction of resistance phenotype from genome sequence data.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.02696.
    PubMed     Abstract available


  106. YAO D, Zhang G, Chen W, Chen J, et al
    Pyrogallol and Fluconazole Interact Synergistically In Vitro Against Candida glabrata Through an Efflux-Associated Mechanism.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00100.
    PubMed     Abstract available


  107. OKOLIEGBE IN, Hijazi K, Cooper K, Ironside C, et al
    Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02483.
    PubMed     Abstract available


  108. POULSEN JS, Madsen AM, White JK, Nielsen JL, et al
    Physiological responses of Aspergillus niger challenged with itraconazole.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02549.
    PubMed     Abstract available


    March 2021
  109. GIL-MARQUES ML, Jacoby GA, Hooper DC
    Analyzing possible native functions of the quinolone resistance gene qnr in Vibrio vulnificus.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00232.
    PubMed     Abstract available


  110. SICELOFF AT, Ohta N, Norman KN, Loneragan GH, et al
    Antimicrobial resistance hidden within multi-serovar Salmonella populations.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00048.
    PubMed     Abstract available


  111. STEWART AG, Price EP, Schabacker K, Birikmen M, et al
    Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00130.
    PubMed     Abstract available


  112. MENGUAL-CHULIA B, Alonso-Cordero A, Cano L, Del Mar Mosquera M, et al
    Surveillance of Influenza A resistance to polymerase complex inhibitors by whole genome analysis, 2016-17, 2017-18 and 2018-19 Seasons, Eastern Spain.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.02718.
    PubMed     Abstract available


  113. ORTIZ DE LA ROSA JM, Nordmann P, Poirel L
    Antioxidant molecules as a source of mitigation of antibiotic resistance genes dissemination.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02658.
    PubMed     Abstract available


  114. HIRVONEN VHA, Spencer J, van der Kamp MW
    Antimicrobial resistance conferred by OXA-48 beta-lactamases:towards a detailed mechanistic understanding.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.00184.
    PubMed     Abstract available


  115. MASUKO A, Takata I, Fujita K, Okumura H, et al
    In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  116. BOOT W, Schmid T, D'Este M, Guillaume O, et al
    A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  117. NAKAMURA R, Oota M, Matsumoto S, Sato T, et al
    In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  118. MIRA PM, Ostman B, Guzman-Cole C, Sindi S, et al
    Adaptive Processes Change as Multiple Functions Evolve.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  119. DIAZ-GARCIA J, Mesquida A, Sanchez-Carrillo C, Reigadas E, et al
    Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  120. CAMP J, Schuster S, Vavra M, Schweigger T, et al
    Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  121. CHENG J, Yan J, Reyna Z, Slarve M, et al
    Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  122. KARAU MJ, Schmidt-Malan SM, Mandrekar J, Lehoux D, et al
    Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.00117.
    PubMed     Abstract available


  123. MODLIN SJ, Marbach T, Werngren J, Mansjo M, et al
    Atypical Genetic Basis of Pyrazinamide Resistance in Mono-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.01916.
    PubMed     Abstract available


  124. ARDIZZONI E, Ariza E, Mulengwa D, Mpala Q, et al
    Thin layer agar-based direct phenotypic drug-susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance, otherwise missed by WHO endorsed diagnostic tests.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02263.
    PubMed     Abstract available


  125. WEI Y, Sluis-Cremer N
    Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand-Transfer Inhibitor Resistance.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02432.
    PubMed     Abstract available


  126. CHO HK, Karau MJ, Greenwood-Quaintance KE, Hansford KA, et al
    In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02443.
    PubMed     Abstract available


  127. MOHD SAZLLY LIM S, Heffernan AJ, Roberts JA, Sime FB, et al
    Semi-mechanistic PK/PD modelling of fosfomycin and sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02472.
    PubMed     Abstract available


  128. ERSOY SC, Chambers HF, Proctor RA, Rosato AE, et al
    Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02621.
    PubMed     Abstract available


    February 2021
  129. ATTERBY C, Nykvist M, Lustig U, Andersson DI, et al
    Selection of Resistant Bacteria in Mallards Exposed to Subinhibitory Concentrations of Ciprofloxacin in Their Water Environment.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  130. FANG Y, Kirsch JR, Li L, Brooks SA, et al
    Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  131. WANG G, Brunel JM, Bolla JM, Van Bambeke F, et al
    The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  132. LI Y, Li Y, Xiu L, Zeng Y, et al
    Typing of Neisseria Gonorrhoeae isolates in Shenzhen, China from 2014-2018 reveals the shift of genotypes associated with antimicrobial resistance.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02311.
    PubMed     Abstract available


  133. FEN SHY, Tandhavanant S, Phunpang R, Ekchariyawat P, et al
    Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of beta-lactam-resistant isolates.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02230.
    PubMed     Abstract available


  134. SHIRIAEV DI, Sofronova AA, Berdnikovich EA, Lukianov DA, et al
    Nybomycin inhibits both types of E. coli DNA gyrase - fluoroquinolone-sensitive and fluoroquinolone-resistant.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.00777.
    PubMed     Abstract available


  135. DUMKE R
    Antimicrobial resistance in clinical isolates of Ureaplasma spp. from samples in Germany.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02342.
    PubMed     Abstract available


  136. LI L, Zhang M, Wang W, Xia R, et al
    Identification and characterization of two novel ISCR1-associated genes dfrA42 and dfrA43 encoding trimethoprim resistant dihydrofolate reductases.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02010.
    PubMed     Abstract available


    January 2021
  137. SMITH NM, Ang A, Tan F, Macias K, et al
    Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro beta-lactam exposure.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.02414.
    PubMed     Abstract available


  138. OLIVER MB, Fong K, Certain L, Spivak ES, et al
    Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  139. YANG J, Liu L, Feng Y, He D, et al
    Potential Mobilization of mcr-10 by an Integrative Mobile Element via Site-Specific Recombination in Cronobacter sakazakii.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  140. KHABTHANI S, Hamel M, Baron SA, Diene SM, et al
    fosM, a New Family of Fosfomycin Resistance Genes Identified in Bacterial Species Isolated from Human Microbiota.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  141. PYBUS CA, Felder-Scott C, Obuekwe V, Greenberg DE, et al
    Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  142. YIN Y, Zhang H, Zhang Y, Hu C, et al
    Fungal Zn(II)2Cys6 Transcription Factor ADS-1 Regulates Drug Efflux and Ergosterol Metabolism under Antifungal Azole Stress.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  143. MOTOS A, Li Bassi G, Pagliara F, Fernandez-Barat L, et al
    Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  144. BURNARD D, Robertson G, Henderson A, Falconer C, et al
    Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  145. YANG X, Ye L, Chan EW, Zhang R, et al
    Characterization of an IncFIB/IncHI1B plasmid encoding efflux pump TMexCD1-TOprJ1 in a clinical tigecycline and carbapenem-resistant Klebsiella pneumoniae strain.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02340.
    PubMed     Abstract available


  146. CHALKER VJ, Sharratt MG, Rees C, Bell OH, et al
    Tetracycline resistance mediated by tet(M) has variable Integrative Conjugative Element composition in Mycoplasma hominis isolated in the United Kingdom from 2005-2015.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02513.
    PubMed     Abstract available


  147. PRATER AG, Mehta HH, Beabout K, Supandy A, et al
    Daptomycin resistance in Enterococcus faecium can be delayed by disruption of the LiaFSR stress response pathway.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01317.
    PubMed     Abstract available


  148. PFALLER MA, Messer SA, Deshpande LM, Rhomberg PR, et al
    Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02031.
    PubMed     Abstract available


  149. CAZER CL, Westblade LF, Simon MS, Magleby R, et al
    Analysis of multidrug resistance in Staphylococcus aureus with a machine learning generated antibiogram.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02132.
    PubMed     Abstract available


  150. DU W, Zhai P, Wang T, Bromley MJ, et al
    The C2H2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target Erg11A and the Drug Efflux Pump Mdr1 in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.01839.
    PubMed     Abstract available


    December 2020
  151. VALAFAR SJ
    A Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02091.
    PubMed     Abstract available


  152. VIMBERG V, Cavanagh JP, Novotna M, Lenart J, et al
    Erratum for Vimberg et al., "Ribosome-Mediated Attenuation of vga(A) Expression Is Shaped by the Antibiotic Resistance Specificity of Vga(A) Protein Variants".
    Antimicrob Agents Chemother. 2020;65.
    PubMed    


  153. SOMPRASONG N, Hall CM, Webb JR, Sahl JW, et al
    Burkholderia ubonensis high-level tetracycline resistance is due to efflux pump synergy involving a novel TetA(64) resistance determinant.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01767.
    PubMed     Abstract available


  154. CHU S, Long L, Sherif R, McCormick TS, et al
    A second generation fungerp analog SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01988.
    PubMed     Abstract available


  155. MARGOT N, Ram R, Rhee M, Callebaut C, et al
    Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.
    Antimicrob Agents Chemother. 2020 Dec 7. pii: AAC.02057.
    PubMed     Abstract available


    November 2020
  156. SAITO S, Hayakawa K, Tsuzuki S, Ishikane M, et al
    The Impact of the Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case-Case-Control Study.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01483.
    PubMed     Abstract available


  157. VIJAY S, Nhung HN, Bao NLH, Thu DDA, et al
    Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01439.
    PubMed     Abstract available


  158. ASADZADEH M, Dashti M, Ahmad S, Alfouzan W, et al
    Whole genome and targeted-amplicon sequencing of fluconazole-susceptible and -resistant Candida parapsilosis isolates from Kuwait reveals a previously undescribed N1132D polymorphism in CDR1.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01633.
    PubMed     Abstract available


  159. SCHUSTER S, Vavra M, Koser R, Rossen JWA, et al
    New topoisomerase inhibitors: Evaluating the potency of gepotidacin and zoliflodacin in fluoroquinolone-resistant Escherichia coli upon tolC inactivation and differentiating their efflux pump substrate nature.
    Antimicrob Agents Chemother. 2020 Nov 16. pii: AAC.01803.
    PubMed     Abstract available


  160. DULYAYANGKUL P, Calvopina K, Heesom KJ, Avison MB, et al
    Novel mechanisms of efflux-mediated levofloxacin resistance and reduced amikacin susceptibility in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01284.
    PubMed     Abstract available


  161. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    PubMed     Abstract available


    October 2020
  162. ARUN KB, Madhavan A, Abraham B, Balaji M, et al
    Acetylation of isoniazid - a novel mechanism of isoniazid resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.00456.
    PubMed     Abstract available


  163. WILLBY M, Chopra P, Lemmer D, Klein K, et al
    Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01663.
    PubMed     Abstract available


  164. BUEHRLE DJ, Decker BK, Wagener MM, Adalja A, et al
    Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  165. BING J, Hu T, Zheng Q, Munoz JF, et al
    Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01466.
    PubMed     Abstract available


  166. NAVARRO-RODRIGUEZ P, Lopez-Fernandez L, Martin-Vicente A, Guarro J, et al
    ERG11 polymorphism in voriconazole-resistant Candida tropicalis. Weak role of ERG11 expression, ergosterol content and membrane permeability.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.00325.
    PubMed     Abstract available


  167. BATTAGLINI D, Motos A, Bassi GL, Yang H, et al
    Efficacy of telavancin in comparison to linezolid in a porcine model of severe methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.01009.
    PubMed     Abstract available


  168. SAKOULAS G
    Imipenem/Cilistatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.02039.
    PubMed     Abstract available


  169. NESPOROVA K, Wyrsch ER, Valcek A, Bitar I, et al
    Escherichia coli ST457: an emerging extended-spectrum beta-lactam resistant lineage with reservoirs in wildlife and food-producing animals.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01118.
    PubMed     Abstract available


  170. SERRANO-LOBO J, Gomez A, Sanchez-Yebra W, Fajardo M, et al
    Azole and amphotericin B minimum inhibitory concentrations against Aspergillus fumigatus: high agreement between spectrophotometric and visual readings using the EUCAST 9.3.2 procedure.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01693.
    PubMed     Abstract available


  171. ZHOU YF, Liu P, Dai SH, Sun J, et al
    Activity of tigecycline or colistin in combination with zidovudine against Escherichia coli harboring tet(X) and mcr-1.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01172.
    PubMed     Abstract available


    September 2020
  172. CACACI M, Menchinelli G, Torelli R, Sanglard D, et al
    Fenticonazole against Fluconazole-Resistant Candida Species: New In Vitro Activity Data.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01459.
    PubMed     Abstract available


  173. MATSUMOTO S, Kanazawa S, Sato T, Yamano Y, et al
    Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-resistant Gram-negative Bacilli in an In Vitro Chemostat Model.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.01128.
    PubMed     Abstract available


  174. LIM HJ, Shin JH, Kim MN, Yong D, et al
    Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.00740.
    PubMed     Abstract available


    August 2020
  175. NELSON K, Rubio-Aparicio D, Tsivkovski R, Sun D, et al
    In Vitro Activity of the Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.01406.
    PubMed     Abstract available


  176. MADUNA LD, Kock MM, van der Veer BMJW, Radebe O, et al
    Antimicrobial resistance of Neisseria gonorrhoeae isolates from high risk men in Johannesburg, South Africa.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00906.
    PubMed     Abstract available


  177. WANG C, Ye C, Liao L, Wang Z, et al
    Adjuvant beta-lactam therapy combined with vancomycin or daptomycin for methicillin-resistant Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01377.
    PubMed     Abstract available


  178. SABET M, Tarazi Z, Griffith DC
    In Vivo Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, In Combination with Beta-Lactams Against Carbapenem-Resistant K. pneumoniae.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01267.
    PubMed     Abstract available


  179. WANG YC, Tang HL, Liao YC, Chiou CS, et al
    Erratum for Wang et al., "Cocarriage of Distinct bla KPC-2 and bla OXA-48 Plasmids in a Single Sequence Type 11 Carbapenem-Resistant Klebsiella pneumoniae Isolate".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  180. HAGMANN SHF, Angelo KM, Huits R, Plewes K, et al
    Epidemiological, and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of their Isolates: A GeoSentinel Analysis.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01084.
    PubMed     Abstract available


  181. VIMBERG V, Cavanagh JP, Novotna M, Lenart J, et al
    Ribosome-mediated attenuation of vga(A) expression is shaped by the antibiotic resistance specificity of Vga(A) protein variants.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00666.
    PubMed     Abstract available


  182. IWATA S, Tada T, Hishinuma T, Mari T, et al
    Emergence of carbapenem-resistant Providencia rettgeri and Providencia stuartti producing IMP-type metallo-beta-lactamase in Japan.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00382.
    PubMed     Abstract available


  183. KIM HL, Rodriguez RD, Morris SK, Zhao S, et al
    Identification of a Novel Plasmid-Borne Gentamicin Resistance Gene in Non-typhoidal Salmonella Isolated From Retail Turkey.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00867.
    PubMed     Abstract available


  184. ISNARD C, Hernandez SB, Guerin F, Joalland F, et al
    Unexpected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.01261.
    PubMed     Abstract available


  185. GODEUX AS, Svedholm E, Lupo A, Haenni M, et al
    Scarless removal of large resistance island AbaR results in antibiotic susceptibility and increased natural transformability in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.00951.
    PubMed     Abstract available


  186. KIM H, Kim ES, Lee SC, Yang E, et al
    Decreased incidence of methicillin-resistant Staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01082.
    PubMed     Abstract available


  187. PEIRANO G, Chen L, Kreiswirth BN, Pitout JDD, et al
    Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01148.
    PubMed     Abstract available


  188. STAPLETON AE, Wagenlehner FME, Mulgirigama A, Twynholm M, et al
    E. coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection In Women: A Systematic Review.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00862.
    PubMed     Abstract available


    July 2020
  189. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Co-Resistance, and Region.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00797.
    PubMed     Abstract available


  190. CAO D, Wu R, Dong S, Wang F, et al
    Azole resistance in environmental Aspergillus fumigatus isolates from China: A five-year survey from 2014 to 2018.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00904.
    PubMed     Abstract available


  191. LIU PY, Lee YL, Lu MC, Shao PL, et al
    National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01089.
    PubMed     Abstract available


  192. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Fang W, et al
    First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and/or Y132F+K143R in Turkey.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01001.
    PubMed     Abstract available


  193. MANKTELOW CJ, Penkova E, Scott L, Matthews A, et al
    Strong environment X genotype interactions determine the fitness costs of antibiotic resistance in vitro and in an insect model of infection.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.01033.
    PubMed     Abstract available


  194. ROUNDTREE MT, Juvvadi PR, Shwab EK, Cole DC, et al
    Aspergillus fumigatus Cyp51A and Cyp51B Proteins are Compensatory in Function and Localize Differentially in Response to Antifungals and Cell Wall Inhibitors.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00735.
    PubMed     Abstract available


  195. HAO M, He Y, Zhang H, Liao XP, et al
    CRISPR/Cas9-mediated carbapenemase genes and plasmids curing in carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00843.
    PubMed     Abstract available


  196. VILCHEZE C, Saranathan R, Weinrick B, Jacobs WR Jr, et al
    Characterization of large deletion mutants of Mycobacterium tuberculosis selected for isoniazid resistance.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00792.
    PubMed     Abstract available


    June 2020
  197. SMITH SJ, Zhao XZ, Passos DO, Lyumkis D, et al
    HIV-1 Integrase Inhibitors that are active against Drug-Resistant Integrase Mutants.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00611.
    PubMed     Abstract available


  198. HAO S, Abdelghany M, Lyden A, Sit R, et al
    Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00961.
    PubMed     Abstract available


  199. ZHU X, Li P, Qian C, Liu H, et al
    Prevalence of Aminoglycoside Resistance Genes and Molecular Characterization of a Novel Gene aac(3)-IIg among Clinical Isolates of Enterobacter cloacae Complex from a Chinese Teaching Hospital.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00852.
    PubMed     Abstract available


  200. LIM TP, Teo JQ, Goh AW, Tan SX, et al
    In vitro Pharmacodynamics of Fosfomycin Against Carbapenem-resistant Enterobacter cloacae & Klebsiella aerogenes.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00536.
    PubMed     Abstract available


  201. PARMAR NR, Singh R, Martin I, Perera SR, et al
    Genomic Analysis Reveals Antibiotic Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae (Saskatchewan, Canada).
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.02514.
    PubMed     Abstract available


  202. SAFI H, Lingaraju S, Ma S, Husain S, et al
    Rapidly-correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small Colony Variant Morphology.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00213.
    PubMed     Abstract available


  203. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00783.
    PubMed     Abstract available


  204. PAIS P, California R, Galocha M, Viana R, et al
    Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance Through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00554.
    PubMed     Abstract available


  205. DURAO P, Ramiro RS, Pereira C, Juric J, et al
    Radial expansion facilitates the maintenance of double antibiotic resistances.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00668.
    PubMed     Abstract available


  206. LUTGRING JD, Balbuena R, Reese N, Gilbert SE, et al
    Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States, 2017-2018.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00499.
    PubMed     Abstract available


  207. COHEN KA, Stott KE, Munsamy V, Manson AL, et al
    Evidence for expanding the role of streptomycin in the management of drug-resistant M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00860.
    PubMed     Abstract available


  208. PI R, Liu Q, Takiff HE, Gao Q, et al
    Fitness Cost and Compensatory Evolution in Levofloxacin-Resistant Mycobacterium aurum.
    Antimicrob Agents Chemother. 2020 Jun 1. pii: AAC.00224.
    PubMed     Abstract available


  209. NELSON K, Rubio-Aparicio D, Sun D, Dudley M, et al
    In Vitro Activity of the Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales (CRE) With Varying Intrinsic and Acquired Resistance Mechanisms.
    Antimicrob Agents Chemother. 2020 Jun 1. pii: AAC.00757.
    PubMed     Abstract available


    May 2020
  210. CAMPOS M, San Millan A, Sempere JM, Lanza VF, et al
    Simulating the Influence of Conjugative Plasmids Kinetic Values on the Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model.
    Antimicrob Agents Chemother. 2020 May 26. pii: AAC.00593.
    PubMed     Abstract available


  211. HUANG HN, Pan CY, Chan YL, Chen JY, et al
    Retraction for Huang et al., "Use of the Antimicrobial Peptide Pardaxin (GE33) To Protect against Methicillin-Resistant Staphylococcus aureus Infection in Mice with Skin Injuries".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  212. THAPA E, Knauss HM, Colvin BA, Fischer BA, et al
    Persistence Dynamics of Antimicrobial Resistant Neisseria in the Pharynx of Rhesus Macaques.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02232.
    PubMed     Abstract available


  213. ZILBERBERG MD, Nathanson BH, Sulham K, Shorr AF, et al
    Antimicrobial susceptibility and cross-resistance patterns among common complicated urinary tract infections in US hospitals, 2013-2018.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.00346.
    PubMed     Abstract available


  214. MACEDO D, Brito Devoto T, Pola S, Finquelievich JL, et al
    A novel combination of CYP51A mutations confers pan-azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02501.
    PubMed     Abstract available


  215. KEBRIAEI R, Lev K, Morrisette T, Stamper K, et al
    Bacteriophage-Antibiotic Combination Strategy: An Alternative against Methicillin-resistant Phenotypes of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00461.
    PubMed     Abstract available


  216. SFEIR MM
    Methicillin-resistant Staphylococcus aureus (MRSA) nasal screening: Clinical use for excluding diabetic foot infection with MRSA.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00635.
    PubMed     Abstract available


  217. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    Reply to Sfeir, "Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA".
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00803.
    PubMed     Abstract available


  218. ADAMS SE, Lugovtsev VY, Kan A, Bovin NV, et al
    Laninamivir-Interferon-lambda1 Combination Treatment Promotes Resistance by Influenza A Virus More Rapidly Than Laninamivir Alone.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00301.
    PubMed     Abstract available


  219. WILSEY HA, Burgess DR, Burgess DS
    Focusing the lens on the CAMERA concepts: Early combination beta-lactam and vancomycin therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00360.
    PubMed     Abstract available


  220. SHIRAKAWA T, Sekizuka T, Kuroda M, Suzuki S, et al
    Comparative Genomic Analysis of Third Generation Cephalosporin-Resistant Escherichia coli Harboring bla CMY-2-Positive IncI1 group, IncB/O/K/Z, and IncC Plasmids Isolated from Healthy Broilers in Japan.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.02385.
    PubMed     Abstract available


    April 2020
  221. SHAH SU, Xiong YQ, Abdelhady W, Iwaz J, et al
    Effect of the Lysin, Exebacase, on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus (MRSA) Endocarditis as Determined by Echocardiography.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00482.
    PubMed     Abstract available


  222. KIM D, Yoon EJ, Hong JS, Lee H, et al
    Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.02180.
    PubMed     Abstract available


  223. RODRIGUEZ-NAVARRO J, Miro E, Brown-Jaque M, Hurtado JC, et al
    Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  224. COLQUE CA, Albarracin Orio AG, Feliziani S, Marvig RL, et al
    Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  225. DI J, Zhang J, Cao L, Huang TT, et al
    Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  226. ENDIMIANI A, Bernasconi OJ, Budel T, Campos-Madueno EI, et al
    Whole-Genome Characterization of a Shewanella algae Strain Coharboring bla CTX-M-15 and armA Genes on a Novel IncC Plasmid.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  227. MATSUO N, Nonogaki R, Hayashi M, Wachino JI, et al
    Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  228. HAYASHI M, Nishiyama A, Kitamoto R, Tateishi Y, et al
    Adduct Formation of Delamanid with NAD in Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  229. LIN YT, Cheng YH, Chuang C, Chou SH, et al
    Molecular and Clinical Characterization of Multidrug-Resistant and Hypervirulent Klebsiella pneumoniae Strains from Liver Abscess in Taiwan.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  230. JACOBS MR, Good CE, Hujer AM, Abdelhamed AM, et al
    ARGONAUT II Study of the In Vitro Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  231. PALWE S, Veeraraghavan B, Periasamy H, Khobragade K, et al
    Unorthodox Parenteral beta-Lactam and beta-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  232. ESHAGHI A, Zittermann S, Bharat A, Mulvey MR, et al
    Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  233. KIEFFER N, Poirel L, Mueller L, Mancini S, et al
    ISEcp1-Mediated Transposition Leads to Fosfomycin and Broad-Spectrum Cephalosporin Resistance in Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  234. STOESSER N, Phan HTT, Seale AC, Aiken Z, et al
    Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  235. CASTANHEIRA M, Sader HS, Mendes RE, Jones RN, et al
    Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  236. SADER HS, Carvalhaes CG, Duncan LR, Shortridge D, et al
    Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  237. KARKI P, Mohiuddin SG, Kavousi P, Orman MA, et al
    Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  238. KAYE KS, Boucher HW, Brown ML, Aggrey A, et al
    Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  239. SCHMERER MW, Abrams AJ, Seby S, Thomas JC 4th, et al
    Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  240. OUESLATI S, Retailleau P, Marchini L, Berthault C, et al
    Role of Arginine 214 in the Substrate Specificity of OXA-48.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  241. PFALLER MA, Huband MD, Shortridge D, Flamm RK, et al
    Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  242. HUBAND MD, Mendes RE, Pfaller MA, Lindley JM, et al
    In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  243. MOLINA KC, Morrisette T, Miller MA, Huang V, et al
    The Emerging Role of beta-lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00468.
    PubMed     Abstract available


  244. NARMANDAKH E, Tumenbayar O, Borolzoi T, Erkhembayar B, et al
    Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00537.
    PubMed     Abstract available


  245. HEBERT C, Gao Y, Rahman P, Dewart C, et al
    Prediction of antibiotic susceptibility for urinary tract infection in a hospital setting.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.02236.
    PubMed     Abstract available


  246. ZHAO L, Yan Y, Dai Q, Li X, et al
    Development of Novel Anti-influenza Thiazolides with Relatively Broad-spectrum Antiviral Potentials.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00222.
    PubMed     Abstract available


  247. WANG CH, Siu LK, Chang FY, Tsai YK, et al
    A novel deletion mutation in pmrB contributes to concurrent colistin resistance in carbapenem resistant E. coli ST 405 of clinical origin.
    Antimicrob Agents Chemother. 2020 Apr 13. pii: AAC.00220.
    PubMed     Abstract available


  248. ALMEIDA LM, Lebreton F, Gaca A, Bispo PM, et al
    Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00142.
    PubMed     Abstract available


  249. BROWN MM, Kwiecinski JM, Mejia Cruz L, Shahbandi A, et al
    Novel peptide from commensal Staphylococcus simulans blocks MRSA quorum sensing and protects host skin from damage.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00172.
    PubMed     Abstract available


    March 2020
  250. YANG T, Pan L, Wu N, Wang L, et al
    Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying the quinolone resistance.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02560.
    PubMed     Abstract available


  251. MASI M, Pinet E, Pages JM
    Complex response of the CpxAR two-component system to beta-lactams on antibiotic resistance and envelop homeostasis in Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.00291.
    PubMed     Abstract available


  252. PFALLER MA, Carvalhaes C, Messer SA, Rhomberg PR, et al
    Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  253. SHIELDS RK
    Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  254. TSIVKOVSKI R, Lomovskaya O
    Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  255. COPPI M, Di Pilato V, Monaco F, Giani T, et al
    Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  256. BONNIN RA, Jousset AB, Gauthier L, Emeraud C, et al
    First Occurrence of the OXA-198 Carbapenemase in Enterobacterales.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  257. ALAMARAT ZI, Babic J, Tran TT, Wootton SH, et al
    Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-beta-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  258. LI J, Lovern M, Riccobene T, Carrothers TJ, et al
    Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  259. PETRAITIENE R, Petraitis V, Kavaliauskas P, Maung BBW, et al
    Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  260. BEN JEDDOU F, Falconnet L, Luscher A, Siriwardena T, et al
    Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  261. SHAW D, Singh S, Dogra S, Jayaraman J, et al
    MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  262. MOON SH, Kaufmann Y, Huang E
    Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against mcr-1-Mediated Polymyxin-Resistant Escherichia coli In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  263. PUJA H, Bolard A, Nogues A, Plesiat P, et al
    The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  264. WEBB BJ, Subramanian A, Lopansri B, Goodman B, et al
    Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  265. KIEFFER N, Poirel L, Descombes MC, Nordmann P, et al
    Characterization of FosL1, a Plasmid-Encoded Fosfomycin Resistance Protein Identified in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  266. MONTERO M, Domene Ochoa S, Lopez-Causape C, VanScoy B, et al
    Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  267. FU Y, Liu D, Song H, Liu Z, et al
    Development of a Multiplex Real-Time PCR Assay for Rapid Detection of Tigecycline Resistance Gene tet(X) Variants from Bacterial, Fecal, and Environmental Samples.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  268. ARCARI G, Di Lella FM, Bibbolino G, Mengoni F, et al
    A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  269. LOGAN LK, Zhang L, Green SJ, Dorevitch S, et al
    A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  270. GUDIOL C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, et al
    Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  271. GRIMSEY EM, Weston N, Ricci V, Stone JW, et al
    Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  272. MCLEOD SM, Moussa SH, Hackel MA, Miller AA, et al
    In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  273. KOVACIKOVA K, Morren BM, Tas A, Albulescu IC, et al
    6'-beta-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  274. JORGENSEN SCJ, Trinh TD, Zasowski EJ, Lagnf AM, et al
    Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  275. LISTON SD, Whitesell L, Kapoor M, Shaw KJ, et al
    Enhanced efflux pump expression in Candida mutants results in decreased manogepix susceptibility.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.00261.
    PubMed     Abstract available


  276. ENKIRCH T, Werngren J, Groenheit R, Alm E, et al
    Systematic review of whole genome sequencing data to predict phenotypic drug resistance and susceptibility in Swedish Mycobacterium tuberculosis isolates 2016-2018.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02550.
    PubMed     Abstract available


  277. SINGH KV, Arias CA, Murray BE
    Tedizolid as step-down therapy following daptomycin versus continuation of daptomycin against enterococci and Staphylococcus aureus (MRSA/VRSA) in a rat endocarditis model.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02303.
    PubMed     Abstract available


    February 2020
  278. LI Q, Zhao P, Li L, Zhao H, et al
    Engineering a CRISPR Interference System To Repress a Class 1 Integron in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  279. SIOPI M, Tarpatzi A, Kalogeropoulou E, Damianidou S, et al
    Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  280. ZIMMERMAN SM, Lafontaine AJ, Herrera CM, Mclean AB, et al
    A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  281. MORRISSEY I, Olesky M, Hawser S, Lob SH, et al
    In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  282. LIU Y, Tan Y, Islam MM, Cao Y, et al
    Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  283. SONNABEND MS, Klein K, Beier S, Angelov A, et al
    Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  284. HAMDI AM, Fida M, Deml SM, Abu Saleh OM, et al
    Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  285. RAMIREZ S, Fernandez-Antunez C, Mikkelsen LS, Pedersen J, et al
    Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  286. MACK AR, Barnes MD, Taracila MA, Hujer AM, et al
    A Standard Numbering Scheme for Class C beta-Lactamases.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  287. IDOWU T, Zhanel GG, Schweizer F
    A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  288. MONTOYA MC, Beattie S, Alden KM, Krysan DJ, et al
    Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  289. COLEMAN SR, Blimkie T, Falsafi R, Hancock REW, et al
    Multidrug Adaptive Resistance of Pseudomonas aeruginosa Swarming Cells.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  290. MCCORMICK KD, Penrose KJ, Brumme CJ, Harrigan R, et al
    Discordance between Etravirine Phenotype and Genotype-based Predicted Phenotype for Subtype C HIV-1 from First-line Antiretroviral Therapy Failures in South Africa.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02101.
    PubMed     Abstract available


  291. CARVAJAL LP, Rincon S, Echeverri AM, Porras J, et al
    Novel Insights Into The Classification of Staphylococcal beta-Lactamases In Relation To The Cefazolin Inoculum Effect.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02511.
    PubMed     Abstract available


  292. GENGENBACHER M, Zimmerman MD, Sarathy JP, Kaya F, et al
    Tissue distribution of doxycycline in animal models of tuberculosis.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02479.
    PubMed     Abstract available


  293. ZARROUK K, Pham VD, Piret J, Shi R, et al
    Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.01910.
    PubMed     Abstract available


  294. CARVALHAES CG, Sader HS, Flamm RK, Streit JM, et al
    Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from United States and European Medical
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.00175.
    PubMed     Abstract available


  295. ARAI T, Majima H, Watanabe A, Kamei K, et al
    A simple method to detect point mutations in Aspergillus fumigatus cyp51A gene using a Surveyor Nuclease assay.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02271.
    PubMed     Abstract available


  296. HELLEBERG M, Jorgensen KM, Hare RK, Datcu R, et al
    Rezafungin In Vitro Activity against Contemporary Clinical Nordic Candida Isolates and Candida auris Determined by the EUCAST Reference Method.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02438.
    PubMed     Abstract available


    January 2020
  297. EKKELENKAMP MB, Canton R, Diez-Aguilar M, Tunney MM, et al
    Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  298. DJUKOVIC A, Gonzalez-Barbera EM, Sanz J, Artacho A, et al
    High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous beta-Lactams.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  299. KOLPEN M, Jensen PO, Qvist T, Kragh KN, et al
    Biofilms of Mycobacterium abscessus Complex Can Be Sensitized to Antibiotics by Disaggregation and Oxygenation.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  300. FLEISCHMANN WA, Greenwood-Quaintance KE, Patel R
    In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  301. CALVOPINA K, Dulyayangkul P, Avison MB
    Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  302. POIREL L, Palmieri M, Brilhante M, Masseron A, et al
    PFM-Like Enzymes Are a Novel Family of Subclass B2 Metallo-beta-Lactamases from Pseudomonas synxantha Belonging to the Pseudomonas fluorescens Complex.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  303. SONG H, Liu D, Li R, Fu Y, et al
    Polymorphism Existence of Mobile Tigecycline Resistance Gene tet(X4) in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  304. RICHARD M, Gutierrez AV, Kremer L
    Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  305. SUN Q, Xiong K, Yuan Y, Yu J, et al
    Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  306. FANG LX, Jiang Q, Deng GH, He B, et al
    Diverse and Flexible Transmission of fosA3 Associated with Heterogeneous Multidrug Resistance Regions in Salmonella enterica Serovar Typhimurium and Indiana Isolates.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  307. MARGOT N, Ram R, Abram M, Haubrich R, et al
    Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutations and M184V.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02557.
    PubMed     Abstract available


  308. RICARDO E, Grenouillet F, Miranda IM, Silva RM, et al
    Mechanisms of acquired in vivo and in vitro resistance to voriconazole by Candida krusei following exposure to suboptimal drug concentration.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01651.
    PubMed     Abstract available


  309. O'BRIEN B, Chaturvedi S, Chaturvedi V
    In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02195.
    PubMed     Abstract available


  310. ALLAN DS, Del Carmen Parquet M, Savage KA, Holbein BE, et al
    Iron sequestrant DIBI, potential alternative for nares decolonization of MRSA Staphylococcus aureus, is anti-infective and inhibitory for mupirocin resistant isolates.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.02353.
    PubMed     Abstract available


    December 2019
  311. BJUGARD NYBERG H, Draper HR, Garcia-Prats AJ, Thee S, et al
    Population pharmacokinetics and dosing of ethionamide in children with tuberculosis.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01984.
    PubMed     Abstract available


  312. PONTES L, Beraquet CAG, Arai T, Pigolli GL, et al
    Aspergillus fumigatus clinical isolates carrying CYP51A TR34/L98H/S297T/F495I mutation detected after 4 years retrospective azole resistance screening test in Brazil.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02059.
    PubMed     Abstract available


  313. BRYSON D, Hettle AG, Boraston AB, Hobbs JK, et al
    Clinical Mutations that Partially Activate the Stringent Response Confer Multi-Drug Tolerance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02103.
    PubMed     Abstract available


  314. DELLIERE S, Verdurme L, Bigot J, Dannaoui E, et al
    Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B Against azole-susceptible and -resistant Aspergillus section Fumigati clinical isolates.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01597.
    PubMed     Abstract available


  315. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    The Novel Arylamidine T-2307 Demonstrates In vitro and In vivo Activity Against Candida auris.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02198.
    PubMed     Abstract available


    November 2019
  316. FAN H, Chen Y, Duan L, Zhao J, et al
    Characterization of azole resistance in Aspergillus fumigatus from potting soil samples in a Chinese hospital:comparison of two typing methods.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01578.
    PubMed     Abstract available


    October 2019
  317. KANG CK, Song KH, Kim SE, Kim ES, et al
    Durations of Staphylococcus aureus bacteremia according to different phenotypes and a new concept of persistent bacteremia: a prospective cohort study.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01656.
    PubMed     Abstract available


  318. KUIPERS S, Ruth MM, Mientjes M, de Sevaux RGL, et al
    Successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant recipient - a Dutch case report.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01281.
    PubMed     Abstract available


  319. FISCHER K, Nguyen K, LiWang PJ
    Griffithsin retains anti-HIV-1 potency with changes in gp120 glycosylation and complements broadly neutralizing antibodies PGT121 and PGT126.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01084.
    PubMed     Abstract available


  320. KAPOOR M, Moloney M, Soltow QA, Pillar CM, et al
    Evaluation of Resistance Development to the Gwt1 inhibitor Manogepix (APX001A) in Candida Species.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01387.
    PubMed     Abstract available


    September 2019
  321. RICHARDS JP, Cai W, Zill NA, Zhang W, et al
    Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01213.
    PubMed     Abstract available


  322. NUNNALLY NS, Etienne KA, Angulo D, Lockhart SR, et al
    In vitro activity of ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01692.
    PubMed     Abstract available


  323. LAMOTH F, Kontoyiannis DP
    Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01244.
    PubMed     Abstract available


    August 2019
  324. TALBOT JJ, Frisvad JC, Meis JF, Hagen F, et al
    Cyp51A mutations, Extrolite Profiles and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00632.
    PubMed     Abstract available


  325. KISHIMOTO T, Ishida W, Fukuda K, Nakajima I, et al
    Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01088.
    PubMed     Abstract available


  326. WIEDERHOLD NP, Najvar LK, Shaw KJ, Jaramillo R, et al
    Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01120.
    PubMed     Abstract available


  327. NAKAMURA I, Ohsumi K, Takeda S, Katsumata K, et al
    ASP2397, a novel natural compound that exhibits rapid and potent fungicidal activity against Aspergillus species through a specific transporter.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.02689.
    PubMed     Abstract available


  328. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01165.
    PubMed     Abstract available


  329. NISHIMOTO AT, Whaley SG, Wiederhold NP, Zhang Q, et al
    Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01304.
    PubMed     Abstract available


  330. WRIGHT WF, Bejou N, Shields RK, Marr K, et al
    Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


    July 2019
  331. PRATER AG, Mehta HH, Kosgei AJ, Miller WR, et al
    Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00790.
    PubMed     Abstract available


  332. KORYCKA-MACHALA M, Viljoen A, Pawelczyk J, Borowka P, et al
    1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00441.
    PubMed     Abstract available


  333. YOUSFI H, Cassagne C, Ranque S, Rolain JM, et al
    Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00263.
    PubMed     Abstract available


  334. RIVERO-MENENDEZ O, Soto-Debran JC, Medina N, Lucio J, et al
    Molecular identification, antifungal susceptibility testing and mechanisms of azole resistance in Aspergillus spp. received within a surveillance program on antifungal resistance in Spain.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00865.
    PubMed     Abstract available


  335. VATANSHENASSAN M, Arastehfar A, Boekhout T, Berman J, et al
    Rapid antifungal susceptibility testing of Candida glabrata isolates against anidulafungin from positive blood culture by MBT ASTRA.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00554.
    PubMed     Abstract available


  336. GHODOUSI A, Rizvi AH, Baloch AQ, Ghafoor A, et al
    Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in Pakistan.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00915.
    PubMed     Abstract available


  337. LI Q, Cheng J, Wu Y, Wang Z, et al
    Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00623.
    PubMed     Abstract available


    June 2019
  338. SEWELL TR, Zhang Y, Brackin AP, Shelton JMG, et al
    Elevated prevalence of azole resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00548.
    PubMed     Abstract available


  339. REHBERG N, Omeje E, Ebada SS, van Geelen L, et al
    3-O-Methyl-alkylgallates inhibit fatty acid desaturation in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00136.
    PubMed     Abstract available


  340. HIND CK, Dowson CG, Sutton JM, Jackson T, et al
    Evaluation of a library of FDA-approved drugs for their ability to potentiate antibiotics against multidrug resistant Gram-negative pathogens.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00769.
    PubMed     Abstract available


  341. BARNARD JP, Huber KD, Sluis-Cremer N
    NNRTI Hyper-Susceptibility and Resistance: Mutational Analysis of Residue 181 in HIV-1 Reverse Transcriptase.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00676.
    PubMed     Abstract available


    May 2019
  342. CHOUDHARY DK, Bhakt P, Kaur R
    An essential role for the PI(3,5)P2 synthesis complex in caspofungin tolerance and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00886.
    PubMed     Abstract available


  343. THEYS K, Libin PJK, Van Laethem K, Abecasis AB, et al
    An evolutionary-based approach to quantify the genetic barrier to drug resistance in fast-evolving viruses: an application to HIV-1 subtypes and integrase inhibitors.
    Antimicrob Agents Chemother. 2019 May 20. pii: AAC.00539.
    PubMed     Abstract available


  344. TAKAMATSU Y, Aoki M, Bulut H, Das D, et al
    Novel protease inhibitors containing C-5-modified bis-THF and aminobenzothiazole as P2 and P2' ligands that exert potent antiviral activity against highly multidrug-resistant HIV-1 with high genetic barrier against the emergence of drug resistance.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00372.
    PubMed     Abstract available


  345. AMANO M, Salcedo-Gomez PM, Yedidi RS, Zhao R, et al
    Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00466.
    PubMed     Abstract available


  346. PEREZ-CANTERO A, Lopez-Fernandez L, Guarro J, Capilla J, et al
    New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00543.
    PubMed     Abstract available


  347. LARKIN EL, Long L, Isham N, Borroto-Esoda K, et al
    A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  348. KO KKK, Chio MTW, Goh SS, Tan AL, et al
    First Case of Ceftriaxone-Resistant Multidrug-Resistant Neisseria gonorrhoeae in Singapore.
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  349. FLAMM RK, Rhomberg PR, Lindley JM, Sweeney K, et al
    Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  350. ROSENBLATT J, Vargas-Cruz N, Reitzel RA, Raad II, et al
    Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  351. LI J, Hao H, Dai M, Zhang H, et al
    Resistance and Virulence Mechanisms of Escherichia coli Selected by Enrofloxacin in Chicken.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  352. DEMUYSER L, Van Dyck K, Timmermans B, Van Dijck P, et al
    Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


    April 2019
  353. ADDETIA A, Greninger AL, Adler A, Yuan S, et al
    A novel, widespread qacA allele results in reduced chlorhexidine susceptibility in Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.02607.
    PubMed     Abstract available


  354. KEBRIAEI R, Rice SA, Stamper KC, Seepersaud R, et al
    Daptomycin Dose-Ranging Evaluation with Single vs. Multi-Dose Ceftriaxone Combinations against Streptococcus mitis-oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00386.
    PubMed     Abstract available


  355. SIOPI M, Mouton J, Pournaras S, Meletiadis J, et al
    In vitro and in vivo exposure-effect relationship of liposomal amphotericin B against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02673.
    PubMed     Abstract available


  356. LOISEAU C, Brites D, Moser I, Coll F, et al
    Revised interpretation of the Hain Lifescience GenoType MTBC to differentiate Mycobacterium canettii and members of the M. tuberculosis complex.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00159.
    PubMed     Abstract available


  357. RANJAN R, Srivastava A, Bharti R, Roy T, et al
    Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00099.
    PubMed     Abstract available


  358. ARASTEHFAR A, Daneshnia F, Zomorodian K, Najafzadeh MJ, et al
    Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples from multicenter (2015-2018): Potential prognostic values of genotyping and sequencing of PDR1.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02503.
    PubMed     Abstract available


    March 2019
  359. NISHIMOTO AT, Wiederhold NP, Flowers SA, Zhang Q, et al
    In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.00341.
    PubMed     Abstract available


  360. BECCARI MV, Mogle BT, Sidman EF, Mastro KA, et al
    Ibalizumab: A novel monoclonal antibody for the management of multidrug resistant HIV-1 infection.
    Antimicrob Agents Chemother. 2019 Mar 18. pii: AAC.00110.
    PubMed     Abstract available


  361. BUTTS A, Reitler P, Nishimoto AT, DeJarnette C, et al
    A systematic screen reveals a diverse collection of medications induce antifungal resistance in Candida species.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00054.
    PubMed     Abstract available


  362. NISHIMOTO AT, Zhang Q, Hazlett B, Morschhauser J, et al
    The contribution of clinically-derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00078.
    PubMed     Abstract available


    February 2019
  363. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Whole-genome sequencing analysis of multidrug-resistant serotype 15A Streptococcus pneumoniae in Japan and the emergence of a highly resistant serotype 15A-ST9084 clone.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02579.
    PubMed     Abstract available


  364. SMITH RA, Raugi DN, Wu VH, Zavala CG, et al
    Comparison of the Antiviral Activity of Bictegravir Against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.00014.
    PubMed     Abstract available


  365. ACOSTA RK, Willkom M, Martin R, Chang S, et al
    Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients Through 48 Weeks.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02533.
    PubMed     Abstract available


  366. GINGRAS H, Patron K, Bhattacharya A, Leprohon P, et al
    Gain and loss of function screens coupled to next generation sequencing for antibiotic mode of action and resistance studies in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02381.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: